Alexandria Venture Investments and 6 Dimensions Capital have participated in an oversubscribed second round for immunotherapy developer TCR2 Therapeutics.

Artificial intelligence software provider Digital Reasoning boosted its overall funding to $127m with a BNP Paribas-led round featuring HCA, Nasdaq, Square and Barclays.

Mythic, an AI chip developer that emerged out of UM, has closed a $40m round led by SoftBank Ventures that included another corporate venturing unit, Lockheed Martin Ventures.

AI chip developer Mythic has closed a $40m round led by SoftBank Ventures that included another corporate venturing unit, Lockheed Martin Ventures.

Monsanto Growth Ventures has co-led the first round disclosed by Pairwise Plants, an agricultural gene-editing company based on Harvard University research.

The corporates, together with venture firm Yahoo Japan, have committed $100m to a Southeast Asia-focused tech fund that will invest up to $15m at series B stage and later.

Hospital and clinic operator Columbia Asia has secured $210m in a round that containted $140m from Mitsui, which had previously supplied $101m in 2016.

Monsanto Growth Ventures has co-led the first round disclosed by Pairwise Plants, an agricultural gene-editing startup helmed by an ex-Monsanto vice-president.

WuXi PharmaTech and Mayo Clinic-backed anti-ageing disease therapy developer Unity Biotechnology has secured series C funding to take its total equity financing to more than $200m.

Fidelity subsidiary Eight Roads Ventures has attracted $375m for a Europe and Israel-focused fund that will target enterprise, consumer, fintech and healthcare IT.